Patents by Inventor Yoo Ri Moon

Yoo Ri Moon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11905331
    Abstract: The present invention relates to an anti-CD40 antibody binding specifically to CD40 and use thereof and, particularly, provides an anti-CD40 antibody or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same antibody or fragment as an effective ingredient for prevention and/or treatment of cancer, cancer metastasis, infection, and/or immune deficiency diseases.
    Type: Grant
    Filed: November 10, 2017
    Date of Patent: February 20, 2024
    Assignee: KUMHO HT, INC.
    Inventors: Gil Yong Ji, Kwon Pyo Hong, Eui Sup Lee, Yoo Ri Moon, Sangsoon Yoon
  • Patent number: 11820831
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: November 21, 2023
    Assignee: APROGEN INC.
    Inventors: Yoo Ri Moon, Sangsoon Yoon, Jeong Won Hong, Eun Jung Kim, Da Bin Choi
  • Publication number: 20230192875
    Abstract: The present invention relates to an anti-CD40 antibody binding specifically to CD40 and use thereof and, particularly, provides an anti-CD40 antibody or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same antibody or fragment as an effective ingredient for prevention and/or treatment of cancer, cancer metastasis, infection, and/or immune deficiency diseases.
    Type: Application
    Filed: November 10, 2017
    Publication date: June 22, 2023
    Inventors: Gil Yong JI, Kwon Pyo HONG, Eui Sup LEE, Yoo Ri MOON, Sangsoon YOON
  • Publication number: 20220033523
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Application
    Filed: September 30, 2021
    Publication date: February 3, 2022
    Inventors: Yoo Ri MOON, Sangsoon Yoon, Jeong Won Hong, Eun Jung Kim, Da Bin Choi
  • Patent number: 11192959
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: December 7, 2021
    Assignee: APROGEN MEDICINES INC.
    Inventors: Yoo Ri Moon, Sangsoon Yoon, Jeong Won Hong, Eun Jung Kim, Da Bin Choi
  • Patent number: 10975160
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: April 13, 2021
    Assignee: APROGEN KIC INC.
    Inventors: Yoo Ri Moon, Gil Yong Ji
  • Patent number: 10472418
    Abstract: A use of prevention or treatment of lung cancer including an antibody specifically recognizing CD66c in lung cancer or its antigen-binding fragment and a chemotherapeutic agent is provided.
    Type: Grant
    Filed: May 23, 2016
    Date of Patent: November 12, 2019
    Assignee: Dinona
    Inventors: Kwon Pyo Hong, Mi Hyang Shin, Sangsoon Yoon, Gil Yong Ji, Yoo Ri Moon
  • Publication number: 20190276557
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Application
    Filed: November 14, 2017
    Publication date: September 12, 2019
    Inventors: Yoo Ri MOON, Sangsoon YOON, Jeong Won HONG, Eun Jung KIM, Da Bin CHOI
  • Publication number: 20190153116
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Application
    Filed: January 31, 2019
    Publication date: May 23, 2019
    Inventors: Yoo Ri MOON, Gil Yong Ji
  • Patent number: 10246517
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: April 2, 2019
    Assignee: APROGEN KIC INC.
    Inventors: Yoo Ri Moon, Gil Yong Ji
  • Publication number: 20170342161
    Abstract: Provided is an antibody that recognizes and binds to carbonic anhydrase or antigen-binding fragment, a nucleic acid molecule coding for the antibody or antigen-binding fragment, a vector carrying the nucleic acid molecule, a host cell including the nucleic acid molecule or the vector, and use of the antibody or antigen-binding fragment thereof in the alleviation, prevention, treatment or diagnosis of solid cancers.
    Type: Application
    Filed: November 7, 2016
    Publication date: November 30, 2017
    Inventors: Yoo Ri MOON, Gil Yong JI
  • Publication number: 20170267757
    Abstract: A use of prevention or treatment of lung cancer including an antibody specifically recognizing CD66c in lung cancer or its antigen-binding fragment and a chemotherapeutic agent is provided.
    Type: Application
    Filed: May 23, 2016
    Publication date: September 21, 2017
    Inventors: Kwon Pyo HONG, Mi Hyang Shin, Sangsoon Yoon, Gil Yong Ji, Yoo Ri Moon